Exhibit 99.1

JOINT FILING AGREEMENT

In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including additional amendments thereto) with respect to the shares of Ordinary Share, $0.0001 par value per share, of CASI Pharmaceuticals, Inc., a Cayman corporation. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.

Dated: April 18, 2023

ETP GLOBAL FUND L.P.
By:	EMERGING TECHNOLOGY PARTNERS, LLC General Partner
By:	/s/ Wei-Wu He, Ph.D.
	Name:	Wei-Wu He, Ph.D.
	Title:	Managing Member

EMERGING TECHNOLOGY PARTNERS, LLC
By:	/s/ Wei-Wu He, Ph.D.
	Name:	Wei-Wu He, Ph.D.
	Title:	Managing Member

ETP-BIOHEALTH FUND III L.P.
By: EMERGING TECHNOLOGY PARTNERS, LLC General Partner
By:	/s/ Wei-Wu He, Ph.D.
	Name:	Wei-Wu He, Ph.D.
	Title:	Managing Member

HUIYING MEMORIAL FOUNDATION
By:	/s/ Wei-Wu He, Ph.D.
	Name:	Wei-Wu He, Ph.D.
	Title:	President

/s/ Wei-Wu He, Ph.D.

Wei-Wu He, Ph.D.